HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.

AbstractSCOPE:
Peanut allergy stems from a Th2-biased immune response to peanut allergens leading to IgE production and allergic reactions upon ingestion.
METHODS AND RESULTS:
A model of peanut allergy in C3H/HeJ mice was used to assess whether type A, B, or C CpG oligodeoxynucleotide (ODN) molecules would be effective in: (i) a prophylactic approach to prevent peanut allergy when administered simultaneously with a Th2-skewing adjuvant, and (ii) a therapeutic model to allow for shortened immunotherapy. Type B ODNs were extremely effective in inhibiting anaphylaxis in the sensitization protocol as evidenced by differences in symptom scores, body temperature, and mouse mast cell protease 1 release compared to sham treatment. In the therapeutic model, co-administration of type B ODN plus peanut proteins was highly effective in reducing anaphylactic reactions in mice with established peanut allergy. The therapeutic effect was accompanied by an increase in IFN-γ and peanut-IgG2a, without a significant decrease in peanut IgE or IL-4 responses.
CONCLUSION:
CpG ODNs, especially type B, were highly effective in inducing Th1 responses in mice undergoing induction of peanut allergy, as well as in mice undergoing therapy for established peanut allergy. Interestingly, the IgE response was not significantly altered, suggesting that IgG antibodies may be enough to prevent peanut-induced anaphylaxis.
AuthorsMike Kulis, Balachandra Gorentla, A Wesley Burks, Xiao-Ping Zhong
JournalMolecular nutrition & food research (Mol Nutr Food Res) Vol. 57 Issue 5 Pg. 906-15 (May 2013) ISSN: 1613-4133 [Electronic] Germany
PMID23386314 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Adjuvants, Immunologic
  • Antigens, Plant
  • CPG-oligonucleotide
  • Immunoglobulin G
  • Oligodeoxyribonucleotides
  • Tumor Necrosis Factor-alpha
  • Interleukin-12
  • Immunoglobulin E
  • Interferon-gamma
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Anaphylaxis (immunology, prevention & control)
  • Animals
  • Antigens, Plant (immunology)
  • Arachis (chemistry, immunology)
  • Dendritic Cells (immunology)
  • Female
  • Immunoglobulin E (immunology, metabolism)
  • Immunoglobulin G (immunology)
  • Immunotherapy
  • Interferon-gamma (immunology)
  • Interleukin-12 (blood)
  • Mice
  • Mice, Inbred C3H
  • Oligodeoxyribonucleotides (pharmacology)
  • Peanut Hypersensitivity (blood, immunology, prevention & control)
  • Th1 Cells (immunology, metabolism)
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: